NNIT A/S

DB:5NN Stock Report

Market Cap: €311.5m

NNIT Valuation

Is 5NN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5NN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€13.15
Fair Value
5.3% undervalued intrinsic discount
3
Number of Analysts

Below Fair Value: 5NN (€12.46) is trading below our estimate of fair value (€13.15)

Significantly Below Fair Value: 5NN is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5NN?

Key metric: As 5NN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5NN. This is calculated by dividing 5NN's market cap by their current earnings.
What is 5NN's PE Ratio?
PE Ratio31.8x
EarningsDKK 73.00m
Market CapDKK 2.32b

Price to Earnings Ratio vs Peers

How does 5NN's PE Ratio compare to its peers?

The above table shows the PE ratio for 5NN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average30x
COP CompuGroup Medical SE KGaA
49.3x30.1%€1.2b
NXU Nexus
44.2x16.9%€1.2b
AJ91 DocCheck
18.3xn/a€45.4m
M3V MeVis Medical Solutions
8xn/a€46.2m
5NN NNIT
31.8x38.4%€2.3b

Price-To-Earnings vs Peers: 5NN is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the peer average (30x).

Price to Earnings Ratio vs Industry

How does 5NN's PE Ratio compare vs other companies in the European Healthcare Services Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
5NN 31.8xIndustry Avg. 34.5xNo. of Companies3PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 5NN is good value based on its Price-To-Earnings Ratio (31.8x) compared to the Global Healthcare Services industry average (34.5x).

Price to Earnings Ratio vs Fair Ratio

What is 5NN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5NN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio31.8x
Fair PE Ratio38.3x

Price-To-Earnings vs Fair Ratio: 5NN is good value based on its Price-To-Earnings Ratio (31.8x) compared to the estimated Fair Price-To-Earnings Ratio (38.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 5NN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.46
€16.08
+29.0%
12.3%€18.76€14.07n/a3
Jan ’26€12.50
€16.42
+31.4%
14.3%€18.77€14.08n/a2
Dec ’25€12.06
€16.42
+36.2%
14.3%€18.77€14.08n/a2
Nov ’25€13.72
€19.10
+39.2%
5.3%€20.10€18.09n/a2
Oct ’25€17.34
€19.10
+10.1%
5.3%€20.10€18.09n/a2
Sep ’25€13.92
€19.10
+37.2%
5.3%€20.11€18.10n/a2
Aug ’25€14.10
€18.43
+30.7%
1.8%€18.76€18.09n/a2
Jul ’25€14.20
€18.43
+29.8%
1.8%€18.77€18.10n/a2
Jun ’25€14.44
€18.44
+27.7%
1.8%€18.77€18.10n/a2
May ’25€14.18
€18.43
+30.0%
1.8%€18.77€18.10n/a2
Apr ’25€14.34
€14.08
-1.8%
33.3%€18.77€9.39n/a2
Mar ’25€14.00
€14.08
+0.6%
33.3%€18.78€9.39n/a2
Feb ’25€12.68
€12.74
+0.5%
26.3%€16.09€9.39€12.462
Jan ’25€11.14
€12.74
+14.4%
26.3%€16.09€9.39€12.502
Dec ’24€11.66
€12.74
+9.3%
26.3%€16.09€9.39€12.062
Nov ’24€10.76
€12.75
+18.5%
26.3%€16.10€9.39€13.722
Oct ’24€10.88
€12.75
+17.2%
26.3%€16.10€9.39€17.342
Sep ’24€10.68
€12.75
+19.4%
26.3%€16.10€9.39€13.922
Aug ’24€10.72
€12.75
+18.9%
26.3%€16.10€9.39€14.102
Jul ’24€10.30
€12.76
+23.8%
26.3%€16.11€9.40€14.202
Jun ’24€11.08
€12.76
+15.1%
26.3%€16.11€9.40€14.442
May ’24€9.53
€12.75
+33.8%
26.3%€16.10€9.39€14.182
Apr ’24€9.06
€12.75
+40.7%
26.3%€16.10€9.39€14.342
Mar ’24€9.47
€12.09
+27.6%
33.3%€16.12€8.06€14.002
Feb ’24€8.85
€12.10
+36.7%
33.3%€16.13€8.07€12.682
Analyst Price Target
Consensus Narrative from 3 Analysts
€16.01
Fair Value
22.2% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 03:00
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NNIT A/S is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Niels Granholm-LethCarnegie Investment Bank AB
Poul JessenDanske Bank